Apologies @w_i_z_z_a I confused Dementia with Parkinsons.....maybe I have early on-set dementia
So yes potentially Neuren's NNZ-2591 MOA could be effective albeit I'm comfortable that their experience with Retts & Trofinetide gives them a massive head start with the 4 other rare diseases (there's not many other co. exploring treatments for those 4) in lieu of putting time, energy and significant $ into a field that has myriad no. of companies developing drugs for Parkinsons.
- Forums
- ASX - By Stock
- NEU
- Ann: Investor Presentation, 14 March 2023
Ann: Investor Presentation, 14 March 2023, page-92
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.86 |
Change
0.640(3.17%) |
Mkt cap ! $2.666B |
Open | High | Low | Value | Volume |
$20.45 | $21.10 | $20.39 | $9.299M | 447.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 671 | $20.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.86 | 262 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1926 | 20.820 |
1 | 2000 | 20.760 |
2 | 1084 | 20.740 |
1 | 5234 | 20.720 |
3 | 2472 | 20.710 |
Price($) | Vol. | No. |
---|---|---|
20.860 | 262 | 1 |
20.920 | 23 | 1 |
20.930 | 1080 | 1 |
20.950 | 3084 | 3 |
20.980 | 1080 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |